NewsFlash Archive

more Events

Subscribe

  • 0%
    0 votes

    Sleep Disorder May Signal Dementia, Parkinson's Disease Up to 50 Years Early

    Thursday, July 29, 2010

    ST. PAUL, Minn. -- A new study shows that a sleep disorder may be a sign of dementia or Parkinson's disease up to 50 years before the disorders are diagnosedThe research is published in the July 28, 2010, online issue of Neurology®, the medical journal of the American Academy of NeurologyUsin

    read more>>

  • 0%
    0 votes

    Molecular Mechanism Triggering Parkinson's Disease Identified in Stanford Study

    Thursday, July 29, 2010

    STANFORD, Calif. -- Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's diseaseThis discovery not only may explain how a genetic mutation linked to Parkinson's causes the cells' deat

    read more>>

  • 0%
    0 votes

    Multiple Sclerosis -- Antihypertensive Drug Ameliorate Inflammation in the Brain

    Thursday, July 29, 2010

    Researchers in Heidelberg and Stanford have discovered a new signalling pathway of brain cells that explains how widely used antihypertensive drugs could keep inflammation in multiple sclerosis (MS) in checkThe peptide angiotensin not only raises blood pressure but also activates the immunological

    read more>>

  • 0%
    0 votes

    Test Targets CML Patients Resistant to Gleevec

    Wednesday, July 28, 2010

    A test developed by a Japanese researcher could one day allow doctors to know which of their chronic myeloid leukemia patients could become resistant to the standard drug used to treat the form of blood cancerA number of drugs now being developed are intended for use in patients who are resistant

    read more>>

  • 0%
    0 votes

    Akonni Awarded $435K NIH Grant to Develop Low Cost Point-of-Care Diagnostics for Mycobacterium Tuberculosis Drug-Resistant Strains

    Wednesday, July 28, 2010

    Frederick, MD -- Akonni Biosystems®, a molecular diagnostics (MDx) company focused on developing and manufacturing rapid, high multiplex solutions for infectious disease testing, today announced receipt of a $435K grant from the National Institutes of Biomedical Imaging and Bioengineering at T

    read more>>

  • 0%
    0 votes

    Morphine Blocks Tumor Growth

    Wednesday, July 28, 2010

    Minneapolis, MN -- Current research suggests that taking morphine can block new blood vessel and tumor growthThe related report by Koodie et al, "Morphine suppresses tumor angiogenesis through a HIF1α/p38MAPK pathway," appears in the August 2010 issue of the American Journal of PathologyMor

    read more>>

  • 0%
    0 votes

    Specific Oncogene Plays a Role in Lung Squamous Cell Carcinoma

    Wednesday, July 28, 2010

    The identification of an oncogene (called BRF2) specific to lung squamous cell carcinoma suggests that genetic activation of this oncogene could be used as an identification marker for this type of lung cancerFurthermore, this oncogene may provide a new target for therapeutics for lung squamous ce

    read more>>

  • 0%
    0 votes

    Listeriosis in the Developing World May Not Follow Usual Pattern

    Wednesday, July 28, 2010

    Rogier van Doorn and colleagues from Ho Chi Minh city, Vietnam present a Learning Forum article in this week's PLoS Medicine that describes three unusual cases of patients with listerial meningitisListeriosis is a foodborne infection caused by Listeria monocytogenes that presents with a sepsis-li

    read more>>

  • 0%
    0 votes

    Light at the End of the Tunnel

    Tuesday, July 27, 2010

    Achromatopsia is a hereditary eye disease for which there is as yet no effective treatmentThe condition is associated with complete lack of color vision, poor visual acuity, hypersensitivity to light and unintentional jittery movement of the eyes (nystagmus). It is due to genetic mutations that pr

    read more>>

  • 0%
    0 votes

    Researchers Create Myocytes That Mimic Long-QT Syndrome

    Tuesday, July 27, 2010

    Munich, Germany -- Researchers have devised a method to create patient-derived cells that can mimic the phenotype that causes long-QT syndrome, which may help in the development of new drug therapies for the disease [1Long-QT syndrome type 1 is caused by a mutation in the KCNQ1 gene, which encodes

    read more>>